Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages

Aim. To study the level of MMP-9 and VCAM-1 in patients with AMI with ST-segment elevation at the hospital stage and one year after the index event, depending on the development of complications and changes in BMI and waist size (WS). Material and methods. The study included 126 people with STEMI...

Full description

Bibliographic Details
Main Authors: Irina N. Zakovryashina, Vladislav A. Suroedov, Larisa A. Khaisheva, Sergey V. Shlyk, Azat S. Samakaev
Format: Article
Language:English
Published: Concilium Medicum 2021-10-01
Series:КардиоСоматика
Subjects:
Online Access:https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/83268/63762
_version_ 1818346394594836480
author Irina N. Zakovryashina
Vladislav A. Suroedov
Larisa A. Khaisheva
Sergey V. Shlyk
Azat S. Samakaev
author_facet Irina N. Zakovryashina
Vladislav A. Suroedov
Larisa A. Khaisheva
Sergey V. Shlyk
Azat S. Samakaev
author_sort Irina N. Zakovryashina
collection DOAJ
description Aim. To study the level of MMP-9 and VCAM-1 in patients with AMI with ST-segment elevation at the hospital stage and one year after the index event, depending on the development of complications and changes in BMI and waist size (WS). Material and methods. The study included 126 people with STEMI after PCI, as well as 27 people in the control group. The level of MMP-9 and VCAM-1 in peripheral blood was analyzed. In addition to the standard methods of examination and diagnosis, BMI and WS were measured to identify groups with visceral obesity. The assessment of the frequency and nature of complications after STEMI was performed. Results. The levels of biomarkers of vascular endothelial adhesion molecule type 1 and matrix metalloproteinase type 9 are increased in the acute period of STEMI, statistically significantly reduced, but remain elevated 12 months after the index event, with VCAM-1 by 3.5 times, and MMP by almost 2 times compared to the initial values. The level of MMP-9 is significantly higher in excess body mass index and waist size, and VCAM-1 has no association with visceral obesity. Vascular endothelial adhesion molecules of type 1 and matrix metalloproteinases of type 9 are increased in patients with a fatal outcome, as well as with an increase in the severity of OSN and CHF. The level of matrix metalloproteinase has a strong relationship with fatal outcome and repeated MI, and the vascular endothelial adhesion molecule type 1 has a stronger relationship with the severity of CHF. Conclusion. The article studied markers of systemic inflammation (matrix metalloproteinase type 9 and vascular endothelial adhesion molecules type 1) in patients with ST-segment elevation myocardial infarction, depending on the presence of obesity at the hospital and outpatient stages. Simultaneous determination of MMP-9 and VCAM-1 levels can be used to assess the intensity of the inflammatory process and the risk of adverse outcomes.
first_indexed 2024-12-13T17:17:34Z
format Article
id doaj.art-19cd33b0f66747b597fef0d09d23989d
institution Directory Open Access Journal
issn 2221-7185
2658-5707
language English
last_indexed 2024-12-13T17:17:34Z
publishDate 2021-10-01
publisher Concilium Medicum
record_format Article
series КардиоСоматика
spelling doaj.art-19cd33b0f66747b597fef0d09d23989d2022-12-21T23:37:23ZengConcilium MedicumКардиоСоматика2221-71852658-57072021-10-0112312413110.17816/22217185.2021.3.20104676469Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stagesIrina N. Zakovryashina0https://orcid.org/0000-0001-5487-5847Vladislav A. Suroedov1https://orcid.org/0000-0001-7850-6544Larisa A. Khaisheva2https://orcid.org/0000-0002-2419-4319Sergey V. Shlyk3https://orcid.org/0000-0003-3070-8424Azat S. Samakaev4https://orcid.org/0000-0002-9127-7253Rostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityRostov State Medical UniversityAim. To study the level of MMP-9 and VCAM-1 in patients with AMI with ST-segment elevation at the hospital stage and one year after the index event, depending on the development of complications and changes in BMI and waist size (WS). Material and methods. The study included 126 people with STEMI after PCI, as well as 27 people in the control group. The level of MMP-9 and VCAM-1 in peripheral blood was analyzed. In addition to the standard methods of examination and diagnosis, BMI and WS were measured to identify groups with visceral obesity. The assessment of the frequency and nature of complications after STEMI was performed. Results. The levels of biomarkers of vascular endothelial adhesion molecule type 1 and matrix metalloproteinase type 9 are increased in the acute period of STEMI, statistically significantly reduced, but remain elevated 12 months after the index event, with VCAM-1 by 3.5 times, and MMP by almost 2 times compared to the initial values. The level of MMP-9 is significantly higher in excess body mass index and waist size, and VCAM-1 has no association with visceral obesity. Vascular endothelial adhesion molecules of type 1 and matrix metalloproteinases of type 9 are increased in patients with a fatal outcome, as well as with an increase in the severity of OSN and CHF. The level of matrix metalloproteinase has a strong relationship with fatal outcome and repeated MI, and the vascular endothelial adhesion molecule type 1 has a stronger relationship with the severity of CHF. Conclusion. The article studied markers of systemic inflammation (matrix metalloproteinase type 9 and vascular endothelial adhesion molecules type 1) in patients with ST-segment elevation myocardial infarction, depending on the presence of obesity at the hospital and outpatient stages. Simultaneous determination of MMP-9 and VCAM-1 levels can be used to assess the intensity of the inflammatory process and the risk of adverse outcomes.https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/83268/63762acute myocardial infarctionmarkers of systemic inflammationmatrix metalloproteinase type 9vascular endothelial adhesion molecules of type 1
spellingShingle Irina N. Zakovryashina
Vladislav A. Suroedov
Larisa A. Khaisheva
Sergey V. Shlyk
Azat S. Samakaev
Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages
КардиоСоматика
acute myocardial infarction
markers of systemic inflammation
matrix metalloproteinase type 9
vascular endothelial adhesion molecules of type 1
title Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages
title_full Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages
title_fullStr Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages
title_full_unstemmed Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages
title_short Study of markers of systemic inflammation (matrix metalloproteinase-9, vascular endothelial adhesion molecules of type 1) in patients with <i>ST</i> -segment elevation myocardial infarction at the hospital and outpatient stages
title_sort study of markers of systemic inflammation matrix metalloproteinase 9 vascular endothelial adhesion molecules of type 1 in patients with i st i segment elevation myocardial infarction at the hospital and outpatient stages
topic acute myocardial infarction
markers of systemic inflammation
matrix metalloproteinase type 9
vascular endothelial adhesion molecules of type 1
url https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/83268/63762
work_keys_str_mv AT irinanzakovryashina studyofmarkersofsystemicinflammationmatrixmetalloproteinase9vascularendothelialadhesionmoleculesoftype1inpatientswithistisegmentelevationmyocardialinfarctionatthehospitalandoutpatientstages
AT vladislavasuroedov studyofmarkersofsystemicinflammationmatrixmetalloproteinase9vascularendothelialadhesionmoleculesoftype1inpatientswithistisegmentelevationmyocardialinfarctionatthehospitalandoutpatientstages
AT larisaakhaisheva studyofmarkersofsystemicinflammationmatrixmetalloproteinase9vascularendothelialadhesionmoleculesoftype1inpatientswithistisegmentelevationmyocardialinfarctionatthehospitalandoutpatientstages
AT sergeyvshlyk studyofmarkersofsystemicinflammationmatrixmetalloproteinase9vascularendothelialadhesionmoleculesoftype1inpatientswithistisegmentelevationmyocardialinfarctionatthehospitalandoutpatientstages
AT azatssamakaev studyofmarkersofsystemicinflammationmatrixmetalloproteinase9vascularendothelialadhesionmoleculesoftype1inpatientswithistisegmentelevationmyocardialinfarctionatthehospitalandoutpatientstages